Proceeds from website advertising help sustain Lab Tests Online. AACC is a not-for-profit organization and does not endorse non-AACC products and services.

Shiga toxin-producing Escherichia coli

Print this article
Share this page:
Also known as: E. coli; E. coli O157; E. coli non-O157; STEC
Formal name: E. coli O157 culture; Shiga-like toxin by EIA; Stx gene detection by PCR
Related tests: O&P, Stool Culture

At a Glance

Why Get Tested?

To determine if your gastrointestinal symptoms are due to an infection caused by Escherichia coli bacteria that produce Shiga toxin

When to Get Tested?

When you have acute diarrhea that is persistent, severe and/or bloody

Sample Required?

A fresh liquid or unformed stool sample that does not contain urine or water, collected in a clean dry container; a rectal swab may be collected from infants. Stool and rectal swab may be placed in transport media for delivery to laboratory.

Test Preparation Needed?


The Test Sample

What is being tested?

These tests detect the presence of disease-causing (pathogenic) Escherichia coli that produce Shiga toxins. E. coli bacteria commonly occur in nature and they are a necessary component of the digestive process in humans and most other mammals. Most strains of E. coli are harmless, but pathogenic E. coli can be responsible for inflammation of the stomach and intestines (gastroenteritis). There are multiple subtypes of E. coli that cause diarrheal illness, and they are classified by the mechanisms by which they cause disease. For example, some invade the lining of the intestines, causing inflammation, while others produce toxins.

E. coli that produce poisons called Shiga toxins are generally the only type of E. coli that are tested for in clinical settings from stool specimens. The Shiga toxins associated with these infections are so called because they are related to the toxins produced by another type of disease-causing bacteria, Shigella.

A strain of Shiga toxin-producing E. coli (STEC) called O157:H7 has been responsible for many outbreaks of gastrointestinal illness in the U.S, though there are also non-O157 strains of STEC that are gaining recognition in individual cases and outbreaks. For example, an outbreak of E. coli O104:H4, a non-O157 STEC, was associated with travel to Germany and resulted in 32 deaths in 2011 from eating contaminated sprouts. In 2007, STEC O157:H7 was responsible for 7% of gut-related diseases reported to all U.S. health agencies.

Outbreaks have been linked to the consumption of contaminated food, including undercooked ground beef, unpasteurized juice, raw milk, and raw produce such as leafy greens and alfalfa sprouts. STEC may also be transmitted through contaminated water, contact with farm animals or their environment, and from person to person.

In addition to symptoms of nausea, severe abdominal cramps, watery diarrhea, fatigue, or possible vomiting and low grade fever, STEC infections are often associated with bloody stools and can lead to serious complications, specifically hemolytic uremic syndrome (HUS). HUS is a result of the toxin entering the blood and destroying red blood cells (hemolysis). It can lead to kidney failure (uremia or the build up of nitrogen wastes in the blood) and can be life-threatening. Signs and symptoms include decreased frequency of urination (evidence of uremia), fatigue, and pale skin due to hemolytic anemia. HUS usually develops about a week after the onset of diarrhea.

Approximately 8% of people who are diagnosed with an O157 STEC infection develop HUS. Children, the elderly, and persons with weakened immune systems are at greatest risk. However, most healthy persons recover from a STEC infection within a week and do not develop HUS. Non-O157 Shiga toxin producing E. coli can cause the same symptoms and complications and likely account for 20-50% of STEC infections in the U.S. annually. Different testing techniques are required to identify O157 and non-O157 Shiga toxin-producing E. coli.

How is the sample collected for testing?

A fresh liquid or unformed stool sample is collected in a clean dry container. The stool sample should not be contaminated with urine or water. Once it has been collected, the stool should be taken to the laboratory immediately or refrigerated and taken to the lab as soon as possible. Some laboratories provide transport media to support the survival of the organism from the time of collection until delivery to the laboratory. STEC become difficult to detect in the stool after one week of illness, so the timing of sample collection relative to the onset of illness is important.

NOTE: If undergoing medical tests makes you or someone you care for anxious, embarrassed, or even difficult to manage, you might consider reading one or more of the following articles: Coping with Test Pain, Discomfort, and Anxiety, Tips on Blood Testing, Tips to Help Children through Their Medical Tests, and Tips to Help the Elderly through Their Medical Tests.

Another article, Follow That Sample, provides a glimpse at the collection and processing of a blood sample and throat culture.

Is any test preparation needed to ensure the quality of the sample?

No test preparation is needed.

The Test

Common Questions

Ask a Laboratory Scientist

This form enables you to ask specific questions about your tests. Your questions will be answered by a laboratory scientist as part of a voluntary service provided by one of our partners, American Society for Clinical Laboratory Science. If your questions are not related to your lab tests, please submit them via our Contact Us form. Thank you.

* indicates a required field

Please indicate whether you are a:   

You must provide a valid email address in order to receive a response.

| Read the Disclaimer

Spam Prevention Equation

| |

Article Sources

« Return to Related Pages

NOTE: This article is based on research that utilizes the sources cited here as well as the collective experience of the Lab Tests Online Editorial Review Board. This article is periodically reviewed by the Editorial Board and may be updated as a result of the review. Any new sources cited will be added to the list and distinguished from the original sources used.

(Updated 2011 August 2). MedlinePlus. E. coli enteritis. [Online information]. Available online at Accessed August 2011.

Mayo Clinic staff (2011 July 28). E. coli. [On-line information]. Available online at through Accessed August 2011.

(Updated 2011 July 8). Investigation Update: Outbreak of Shiga toxin-producing E. coli O104 (STEC O104:H4) Infections Associated with Travel to Germany. [Online information]. Available online at through Accessed August 2011.

(Updated 2011 July 8). Escherichia coli O157:H7 and other Shiga toxin-producing Escherichia coli (STEC). [On-line information]. Available online at through Accessed August 2011.

Fisher, M. (Updated 2011 April). Diarrhea, Bacterial Evaluation. ARUP Consult [On-line information]. Available online at through Accessed August 2011.

Couturier, Marc Roger, et al. Shiga-Toxigenic Escherichia coli Detection in Stool Samples Screened for Viral Gastroenteritis in Alberta, Canada. J Clin Microbiol. 2011 February; 49(2): 574–578. doi: 10.1128/JCM.01693-10.

Gould, Hannah, L. et al. (Reviewed 2009 October 1). Recommendations for Diagnosis of Shiga Toxin--Producing Escherichia coli Infections by Clinical Laboratories [Online information]. Available online at through Accessed August 2011.

Levison, Matthew, E., MD. (Reviewed 2008 September). Merck home health handbook. E.coli infections. [Online information]. Available online at through Accessed August 2011.

(Updated 2008 July 5). National Institute of Allergy and Infectious Disease. E. coli [On-line information]. Available online at: through Accessed August 2011.

(March 2008). World Gastroenterology Organisation practice guideline: Acute diarrhea. [On-line information]. Available online at through Accessed August 2011.

Boyce, Thomas, G. MD, MPH (Reviewed 2007 September). Hemorrhagic Colitis Merck home health handbook [Online Information]. Available online at through Accessed August 2011.

Johnson K.E., Thorpe C.M., Sears C.L. The Emerging Clinical Importance of Non-O157 Shiga Toxin–Producing Escherichia coli. Clin Infect Dis. 2006 Dec 15; 43(12):1587-95.

(Reviewed 2004 April 6). Diagnosis and Management of Foodborne Ilness. [On-line information]. Available online at through Accessed August 2011.

Wong C.A., Jelacic S., Habeeb R.L., et al. The risk of the hemolytic-uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 infections. N Engl J Med, 2000 Jun 29; 342(26): 1930-6.

Paton J.C., Paton A.W.. Pathogenesis and diagnosis of shiga toxin producing Escherichia coli infections. Clin Microbiol Rev.1998; 11(3): 450-479.